Suboxone (Buprenorphine Hydrochloride / Naloxone Hydrochloride) - Summary

SUBOXONE SUMMARY

SUBOXONE sublingual tablets contain buprenorphine HCl and naloxone HCl dihydrate at a ratio of 4:1 buprenorphine: naloxone (ratio of free bases).

SUBOXONE and SUBUTEX are indicated for the treatment of opioid dependence.

SUBOXONE NEWS HIGHLIGHTS

Published Studies Related to Suboxone (Buprenorphine / Naloxone)

Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. [2008.03]

A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. [2007.12]

A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. [2007.05]

Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. [2007.02]

Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. [2006.12]

more>>

Clinical Trials Related to Suboxone (Buprenorphine / Naloxone)

Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphin/Naloxone) in Opioid Dependent Patients on Subutex (Study P05094)(COMPLETED) [Completed]

Treatment of Opioid Dependent Patients With Suboxone: Acceptability and Safety From Real Life Scenario (Study P05603) [Recruiting]

A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042) [Recruiting]

A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843) [Recruiting]

Optimizing Outcomes Using Suboxone for Opiate Dependence [Recruiting]

more>>